The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

Actions
  • Price (GBX)786.00
  • Today's Change8.00 / 1.03%
  • Shares traded53.42k
  • 1 Year change-22.94%
  • Beta0.4662
Data delayed at least 20 minutes, as of Jul 14 2025 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Mar 31 2025202520242023
ASSETS
Cash And Short Term Investments8.452.132.77
Total Receivables, Net------
Total Inventory------
Prepaid expenses0.020.030.02
Other current assets, total0150.49
Total current assets8.47173.28
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments217395357
Note receivable - long term------
Other long term assets0.750.04--
Total assets227411361
LIABILITIES
Accounts payable------
Accrued expenses------
Notes payable/short-term debt04720
Current portion long-term debt/capital leases------
Other current liabilities, total4.742.019.10
Total current liabilities5.425030
Total long term debt000
Total debt04720
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities5.425030
SHAREHOLDERS EQUITY
Common stock6.788.379.68
Additional paid-in capital808080
Retained earnings (accumulated deficit)134273241
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity221361330
Total liabilities & shareholders' equity227411361
Total common shares outstanding273339
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.